Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.490
-0.020 (-1.32%)
At close: Jul 31, 2026, 4:00 PM EDT
1.400
-0.090 (-6.04%)
After-hours: Jul 31, 2026, 7:54 PM EDT
Genenta Science Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 |
Selling, General & Admin | 3.9 | 4.15 | 4.4 | 4.68 | 4.95 | 4.9 | 4.86 | 5.06 | 5.26 | 5.66 | 6.07 | 5.89 | 5.71 | 4.84 | 3.97 | 3.13 | 2.3 | 1.82 | 1.34 | 1.12 |
Research & Development | 2.7 | 3.46 | 4.23 | 4.52 | 4.81 | 4.7 | 4.59 | 5.53 | 6.47 | 7.05 | 7.62 | 6.48 | 5.34 | 3.59 | 1.83 | 2.61 | 3.39 | 4.6 | 5.82 | 5.25 |
Total Operating Expenses | 6.6 | 7.62 | 8.63 | 9.2 | 9.76 | 9.61 | 9.45 | 10.59 | 11.73 | 12.71 | 13.69 | 12.37 | 11.04 | 8.42 | 5.8 | 5.74 | 5.69 | 6.42 | 7.15 | 6.37 |
Operating Income | -6.6 | -7.62 | -8.63 | -9.2 | -9.76 | -9.61 | -9.45 | -10.59 | -11.73 | -12.71 | -13.69 | -12.37 | -11.04 | -8.42 | -5.8 | -5.74 | -5.69 | -6.42 | -7.15 | -6.37 |
Interest Income | 0.61 | 0.35 | 0.09 | 0.08 | 0.08 | 0.23 | 0.38 | 0.34 | 0.31 | 0.21 | 0.11 | - | 0.04 | - | - | - | -0.01 | - | - | - |
Other Non-Operating Income (Expense) | -0.53 | -0.52 | -0.51 | -0.04 | 0.95 | 0.35 | 0.27 | 0.08 | -0.11 | 0.16 | 0.42 | 1.46 | 2.74 | 2.28 | 2.05 | 1.03 | 0.17 | 0 | 0 | 0 |
Total Non-Operating Income (Expense) | 0.08 | -0.17 | -0.42 | 0.04 | 1.03 | 0.57 | 0.65 | 0.43 | 0.2 | 0.37 | 0.54 | 1.46 | 2.78 | 2.28 | 2.05 | 1.03 | 0.16 | 0 | 0 | 0 |
Pretax Income | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 | -13.12 | -10.8 | -8.48 | -6.04 | -3.59 | -4.56 | -5.53 | -6.34 | -7.16 | -6.38 |
Net Income | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 | -13.12 | -1.06 | -2.11 | -2.11 | -2.11 | -3.08 | -4.05 | -5.6 | -7.16 | -6.38 |
Net Income to Common | -3.83 | -3.83 | -3.83 | -3.93 | -4.04 | -4.04 | -4.04 | -5.4 | -6.76 | -9.94 | -13.12 | -10.8 | -8.48 | -6.04 | -3.59 | -4.56 | -5.53 | -6.34 | -7.16 | -6.38 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 | 17 | 16 | 15 | 13 | 14 | 13 |
Shares Outstanding (Diluted) | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 | 17 | 16 | 15 | 13 | 14 | 13 |
Shares Change (YoY) | 6.37% | 3.90% | 1.40% | 0.80% | 0.20% | 0.15% | 0.11% | 0.06% | - | - | - | -3.47% | 8.39% | 18.35% | 11.42% | 21.10% | 10.46% | -1.82% | - | - |
EPS (Basic) | -0.33 | -0.40 | -0.47 | -0.48 | -0.49 | -0.49 | -0.49 | -0.56 | -0.64 | -0.68 | -0.72 | -0.59 | -0.47 | 0.10 | -0.22 | -0.29 | -0.37 | -0.58 | -0.09 | -0.04 |
EPS (Diluted) | -0.33 | -0.40 | -0.47 | -0.48 | -0.49 | -0.49 | -0.49 | -0.56 | -0.64 | -0.68 | -0.72 | -0.59 | -0.47 | 0.10 | -0.22 | -0.29 | -0.37 | -0.58 | -0.09 | -0.04 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 |
Free Cash Flow | -6.88 | -8.29 | -9.71 | -7.98 | -6.24 | -5.97 | -5.69 | -8.45 | -11.22 | -11.84 | -12.47 | -9.96 | -7.45 | -6.14 | -4.84 | -5.9 | -6.97 | -7.89 | -8.8 | -7.43 |
Free Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.35 | -0.43 | -0.52 | -0.43 | -0.34 | -0.33 | -0.31 | -0.46 | -0.62 | -0.65 | -0.68 | -0.55 | -0.41 | -0.33 | -0.29 | -0.37 | -0.46 | -0.60 | -0.64 | -0.55 |
EBITDA | -6.58 | -7.58 | -8.59 | -9.16 | -9.72 | -9.56 | -9.41 | -10.55 | -11.69 | -12.68 | -13.67 | -12.35 | -11.04 | -8.42 | -5.79 | -5.74 | -5.68 | -6.42 | -7.15 | -6.37 |
EBIT | -6.6 | -7.62 | -8.63 | -9.2 | -9.76 | -9.61 | -9.45 | -10.59 | -11.73 | -12.71 | -13.69 | -12.37 | -11.04 | -8.42 | -5.8 | -5.74 | -5.69 | -6.42 | -7.15 | -6.37 |